{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:25:10Z","timestamp":1789457110474,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National research foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2017R1E1A1A01074091"],"award-info":[{"award-number":["NRF-2017R1E1A1A01074091"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National research foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2022R1A2C1004019"],"award-info":[{"award-number":["NRF-2022R1A2C1004019"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s12272-022-01396-0","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T11:02:48Z","timestamp":1657364568000},"page":"460-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["STAT3 mediates RCP-induced cancer cell invasion through the NF-\u03baB\/Slug\/MT1-MMP signaling cascade"],"prefix":"10.1007","volume":"45","author":[{"given":"Su Jin","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Soo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Gyo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Yeun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1954-7981","authenticated-orcid":false,"given":"Hoi Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"issue":"Suppl 2","key":"1396_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijgo.12614","volume":"143","author":"JS Berek","year":"2018","unstructured":"Berek JS, Kehoe ST, Kumar L, Friedlander M (2018) Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 143(Suppl 2):59\u201378. https:\/\/doi.org\/10.1002\/ijgo.12614","journal-title":"Int J Gynaecol Obstet"},{"key":"1396_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","volume":"35","author":"CL Chaffer","year":"2016","unstructured":"Chaffer CL, San Juan BP, Lim E, Weinberg RA (2016) EMT, cell plasticity and metastasis. Cancer Metastasis Rev 35:645\u2013654. https:\/\/doi.org\/10.1007\/s10555-016-9648-7","journal-title":"Cancer Metastasis Rev"},{"key":"1396_CR3","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3390\/cancers11111635","volume":"11","author":"C Chesnelong","year":"2019","unstructured":"Chesnelong C, Hao X, Cseh O, Wang AY, Luchman HA, Weiss S (2019) SLUG directs the precursor state of human brain tumor stem cells. Cancers (basel) 11:1635\u20131661.\u00a0https:\/\/doi.org\/10.3390\/cancers11111635","journal-title":"Cancers (basel)"},{"key":"1396_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12272-019-01129-w","volume":"42","author":"KH Cho","year":"2019","unstructured":"Cho KH, Lee HY (2019) Rab25 and RCP in cancer progression. Arch Pharm Res 42:101\u2013112. https:\/\/doi.org\/10.1007\/s12272-019-01129-w","journal-title":"Arch Pharm Res"},{"key":"1396_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12272-018-01108-7","volume":"42","author":"ES Cho","year":"2019","unstructured":"Cho ES, Kang HE, Kim NH, Yook JI (2019a) Therapeutic implications of cancer epithelial-mesenchymal transition (EMT). Arch Pharm Res 42:14\u201324. https:\/\/doi.org\/10.1007\/s12272-018-01108-7","journal-title":"Arch Pharm Res"},{"key":"1396_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12272-019-01149-6","volume":"42","author":"KH Cho","year":"2019","unstructured":"Cho KH, Jeong BY, Park CG, Lee HY (2019b) The YB-1\/EZH2\/amphiregulin signaling axis mediates LPA-induced breast cancer cell invasion. Arch Pharm Res 42:519\u2013530. https:\/\/doi.org\/10.1007\/s12272-019-01149-6","journal-title":"Arch Pharm Res"},{"key":"1396_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0078-1","volume":"50","author":"SR Choe","year":"2018","unstructured":"Choe SR, Kim YN, Park CG, Cho KH, Cho DY, Lee HY (2018) RCP induces FAK phosphorylation and ovarian cancer cell invasion with inhibition by curcumin. Exp Mol Med 50:1\u201310. https:\/\/doi.org\/10.1038\/s12276-018-0078-1","journal-title":"Exp Mol Med"},{"key":"1396_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1054\/bjoc.2000.1553","volume":"84","author":"J Choi","year":"2001","unstructured":"Choi J, Lim H, Nam DK, Kim HS, Cho DY, Yi JW, Kim HC, Cho YK, Kim MW, Joo HJ, Lee KB, Kim KB (2001) Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. Br J Cancer 84:186\u2013192. https:\/\/doi.org\/10.1054\/bjoc.2000.1553","journal-title":"Br J Cancer"},{"key":"1396_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3892\/ol.2012.652","volume":"3","author":"Y Dai","year":"2012","unstructured":"Dai Y, Liu Y, Huang D, Yu C, Cai G, Pi L, Ren C, Chen GZ, Tian Y, Zhang X (2012) Increased expression of Rab coupling protein in squamous cell carcinoma of the head and neck and its clinical significance. Oncol Lett 3:1231\u20131236. https:\/\/doi.org\/10.3892\/ol.2012.652","journal-title":"Oncol Lett"},{"key":"1396_CR10","doi-asserted-by":"publisher","first-page":"10602","DOI":"10.1073\/pnas.0404100101","volume":"101","author":"TN Dechow","year":"2004","unstructured":"Dechow TN, Pedranzini L, Leitch A, Leslie K, Gerald WL, Linkov I, Bromberg JF (2004) Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proc Natl Acad Sci U S A 101:10602\u201310607. https:\/\/doi.org\/10.1073\/pnas.0404100101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1396_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1021\/acschembio.5b00945","volume":"11","author":"SL Furtek","year":"2016","unstructured":"Furtek SL, Backos DS, Matheson CJ, Reigan P (2016) Strategies and approaches of targeting STAT3 for cancer treatment. ACS Chem Biol 11:308\u2013318. https:\/\/doi.org\/10.1021\/acschembio.5b00945","journal-title":"ACS Chem Biol"},{"key":"1396_CR12","doi-asserted-by":"publisher","first-page":"21643","DOI":"10.3390\/ijms160921643","volume":"16","author":"H Gao","year":"2015","unstructured":"Gao H, Teng C, Huang W, Peng J, Wang C (2015) SOX2 promotes the epithelial to mesenchymal transition of esophageal squamous cells by modulating slug expression through the activation of STAT3\/HIF-alpha signaling. Int J Mol Sci 16:21643\u201321657. https:\/\/doi.org\/10.3390\/ijms160921643","journal-title":"Int J Mol Sci"},{"key":"1396_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/14728222.11.1.91","volume":"11","author":"J Homsi","year":"2007","unstructured":"Homsi J, Cubitt C, Daud A (2007) The Src signaling pathway: a potential target in melanoma and other malignancies. Expert Opin Ther Targets 11:91\u2013100. https:\/\/doi.org\/10.1517\/14728222.11.1.91","journal-title":"Expert Opin Ther Targets"},{"key":"1396_CR14","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/onc.2016.277","volume":"36","author":"MH Hwang","year":"2017","unstructured":"Hwang MH, Cho KH, Jeong KJ, Park YY, Kim JM, Yu SL, Park CG, Mills GB, Lee HY (2017) RCP induces slug expression and cancer cell invasion by stabilizing beta1 integrin. Oncogene 36:1102\u20131111. https:\/\/doi.org\/10.1038\/onc.2016.277","journal-title":"Oncogene"},{"key":"1396_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1083\/jcb.201302041","volume":"202","author":"G Jacquemet","year":"2013","unstructured":"Jacquemet G, Green DM, Bridgewater RE, von Kriegsheim A, Humphries MJ, Norman JC, Caswell PT (2013) RCP-driven alpha5beta1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1-IQGAP1 complex. J Cell Biol 202:917\u2013935. https:\/\/doi.org\/10.1083\/jcb.201302041","journal-title":"J Cell Biol"},{"key":"1396_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s12272-016-0795-8","volume":"39","author":"BH Kim","year":"2016","unstructured":"Kim BH, Yi EH, Ye SK (2016) Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment. Arch Pharm Res 39:1085\u20131099. https:\/\/doi.org\/10.1007\/s12272-016-0795-8","journal-title":"Arch Pharm Res"},{"key":"1396_CR17","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s12276-020-0474-1","volume":"52","author":"JY Kim","year":"2020","unstructured":"Kim JY, Cho KH, Jeong BY, Park CG, Lee HY (2020) Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol. Exp Mol Med 52:1152\u20131163. https:\/\/doi.org\/10.1038\/s12276-020-0474-1","journal-title":"Exp Mol Med"},{"key":"1396_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ccr.2009.02.015","volume":"15","author":"H Lee","year":"2009","unstructured":"Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, Forman S, Jove R, Pardoll DM, Yu H (2009) Persistently activated STAT3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15:283\u2013293. https:\/\/doi.org\/10.1016\/j.ccr.2009.02.015","journal-title":"Cancer Cell"},{"key":"1396_CR19","doi-asserted-by":"publisher","first-page":"9671","DOI":"10.1007\/s13277-016-4848-x","volume":"37","author":"S Liu","year":"2016","unstructured":"Liu S, Sun J, Cai B, Xi X, Yang L, Zhang Z, Feng Y, Sun Y (2016) NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer. Tumour Biol 37:9671\u20139680. https:\/\/doi.org\/10.1007\/s13277-016-4848-x","journal-title":"Tumour Biol"},{"key":"1396_CR20","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1158\/0008-5472.CAN-07-0575","volume":"67","author":"HW Lo","year":"2007","unstructured":"Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y, Abbruzzese JL, Hortobagyi GN, Hung MC (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67:9066\u20139076. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0575","journal-title":"Cancer Res"},{"key":"1396_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1447-0756.2009.01045.x","volume":"35","author":"H Min","year":"2009","unstructured":"Min H, Wei-hong Z (2009) Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma. J Obstet Gynaecol Res 35:918\u2013925. https:\/\/doi.org\/10.1111\/j.1447-0756.2009.01045.x","journal-title":"J Obstet Gynaecol Res"},{"key":"1396_CR22","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1038\/onc.2011.107","volume":"30","author":"V Morello","year":"2011","unstructured":"Morello V, Cabodi S, Sigismund S, Camacho-Leal MP, Repetto D, Volante M, Papotti M, Turco E, Defilippi P (2011) beta1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. Oncogene 30:4087\u20134096. https:\/\/doi.org\/10.1038\/onc.2011.107","journal-title":"Oncogene"},{"key":"1396_CR23","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1128\/MCB.00004-10","volume":"30","author":"UK Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay UK, Mooney P, Jia L, Eves R, Raptis L, Mak AS (2010) Doubles game: Src-STAT3 versus p53-PTEN in cellular migration and invasion. Mol Cell Biol 30:4980\u20134995. https:\/\/doi.org\/10.1128\/MCB.00004-10","journal-title":"Mol Cell Biol"},{"key":"1396_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1074\/jbc.M113.502138","volume":"289","author":"PA Muller","year":"2014","unstructured":"Muller PA, Trinidad AG, Caswell PT, Norman JC, Vousden KH (2014) Mutant p53 regulates dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype. J Biol Chem 289:122\u2013132. https:\/\/doi.org\/10.1074\/jbc.M113.502138","journal-title":"J Biol Chem"},{"key":"1396_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/or.19.1.33","volume":"19","author":"T Nakagawa","year":"2008","unstructured":"Nakagawa T, Iida S, Osanai T, Uetake H, Aruga T, Toriya Y, Takagi Y, Kawachi H, Sugihara K (2008) Decreased expression of SOCS-3 mRNA in breast cancer with lymph node metastasis. Oncol Rep 19:33\u201339.\u00a0https:\/\/doi.org\/10.3892\/or.19.1.33","journal-title":"Oncol Rep"},{"key":"1396_CR26","doi-asserted-by":"publisher","first-page":"60395","DOI":"10.18632\/oncotarget.10939","volume":"7","author":"CM Pan","year":"2016","unstructured":"Pan CM, Wang ML, Chiou SH, Chen HY, Wu CW (2016) Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings. Oncotarget 7:60395\u201360406. https:\/\/doi.org\/10.18632\/oncotarget.10939","journal-title":"Oncotarget"},{"key":"1396_CR27","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/onc.2010.517","volume":"30","author":"SY Park","year":"2011","unstructured":"Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, Kim JM, Lee JS, Kang J, Park CG, Mills GB, Lee HY (2011) Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene 30:1351\u20131359. https:\/\/doi.org\/10.1038\/onc.2010.517","journal-title":"Oncogene"},{"key":"1396_CR28","doi-asserted-by":"publisher","first-page":"e0169622","DOI":"10.1371\/journal.pone.0169622","volume":"12","author":"BR Pires","year":"2017","unstructured":"Pires BR, Mencalha AL, Ferreira GM, de Souza WF, Morgado-Diaz JA, Maia AM, Correa S, Abdelhay ES (2017) NF-kappaB is involved in the regulation of EMT genes in breast cancer cells. PLoS ONE 12:e0169622. https:\/\/doi.org\/10.1371\/journal.pone.0169622","journal-title":"PLoS ONE"},{"key":"1396_CR29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1349-7006.2007.00485.x","volume":"98","author":"Z Qiu","year":"2007","unstructured":"Qiu Z, Huang C, Sun J, Qiu W, Zhang J, Li H, Jiang T, Huang K, Cao J (2007) RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci 98:1099\u20131106. https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00485.x","journal-title":"Cancer Sci"},{"key":"1396_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2009.06.023","volume":"288","author":"JH Seo","year":"2010","unstructured":"Seo JH, Jeong KJ, Oh WJ, Sul HJ, Sohn JS, Kim YK, Cho DY, Kang JK, Park CG, Lee HY (2010) Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin. Cancer Lett 288:50\u201356. https:\/\/doi.org\/10.1016\/j.canlet.2009.06.023","journal-title":"Cancer Lett"},{"key":"1396_CR31","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1074\/jbc.M111.308940","volume":"287","author":"MA Shields","year":"2012","unstructured":"Shields MA, Krantz SB, Bentrem DJ, Dangi-Garimella S, Munshi HG (2012) Interplay between beta1-integrin and Rho signaling regulates differential scattering and motility of pancreatic cancer cells by snail and slug proteins. J Biol Chem 287:6218\u20136229. https:\/\/doi.org\/10.1074\/jbc.M111.308940","journal-title":"J Biol Chem"},{"key":"1396_CR32","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s12272-020-01291-6","volume":"43","author":"DG Song","year":"2020","unstructured":"Song DG, Kim E, Lee JW (2020) Metastatic behavior analyses of tetraspanin TM4SF5-expressing spheres in three-dimensional (3D) cell culture environment. Arch Pharm Res 43:1162\u20131172. https:\/\/doi.org\/10.1007\/s12272-020-01291-6","journal-title":"Arch Pharm Res"},{"key":"1396_CR33","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/mc.22438","volume":"55","author":"J Srivastava","year":"2016","unstructured":"Srivastava J, DiGiovanni J (2016) Non-canonical STAT3 signaling in cancer. Mol Carcinog 55:1889\u20131898. https:\/\/doi.org\/10.1002\/mc.22438","journal-title":"Mol Carcinog"},{"key":"1396_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/jcp.22264","volume":"225","author":"G Storci","year":"2010","unstructured":"Storci G, Sansone P, Mari S, D\u2019Uva G, Tavolari S, Guarnieri T, Taffurelli M, Ceccarelli C, Santini D, Chieco P, Marcu KB, Bonafe M (2010) TNFalpha up-regulates SLUG via the NF-kappaB\/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol 225:682\u2013691. https:\/\/doi.org\/10.1002\/jcp.22264","journal-title":"J Cell Physiol"},{"key":"1396_CR35","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1242\/jcs.143420","volume":"127","author":"KM Welch-Reardon","year":"2014","unstructured":"Welch-Reardon KM, Ehsan SM, Wang K, Wu N, Newman AC, Romero-Lopez M, Fong AH, George SC, Edwards RA, Hughes CC (2014) Angiogenic sprouting is regulated by endothelial cell expression of slug. J Cell Sci 127:2017\u20132028. https:\/\/doi.org\/10.1242\/jcs.143420","journal-title":"J Cell Sci"},{"key":"1396_CR36","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1038\/onc.2009.279","volume":"29","author":"SE Wheeler","year":"2010","unstructured":"Wheeler SE, Suzuki S, Thomas SM, Sen M, Leeman-Neill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY, Grandis JR (2010) Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene 29:5135\u20135145. https:\/\/doi.org\/10.1038\/onc.2009.279","journal-title":"Oncogene"},{"key":"1396_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12272-021-01310-0","volume":"44","author":"M Xiang","year":"2021","unstructured":"Xiang M, Huang Y, Dai C, Zou G (2021) MiR-340 regulates the growth and metabolism of renal cell carcinoma cells by targeting frizzled class receptor 3. Arch Pharm Res 44:219\u2013229. https:\/\/doi.org\/10.1007\/s12272-021-01310-0","journal-title":"Arch Pharm Res"},{"key":"1396_CR38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/stem.2320","volume":"34","author":"C Yao","year":"2016","unstructured":"Yao C, Su L, Shan J, Zhu C, Liu L, Liu C, Xu Y, Yang Z, Bian X, Shao J, Li J, Lai M, Shen J, Qian C (2016) IGF\/STAT3\/NANOG\/Slug signaling axis simultaneously controls epithelial-mesenchymal transition and stemness maintenance in colorectal cancer. Stem Cells 34:820\u2013831. https:\/\/doi.org\/10.1002\/stem.2320","journal-title":"Stem Cells"},{"key":"1396_CR39","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1172\/JCI37622","volume":"119","author":"J Zhang","year":"2009","unstructured":"Zhang J, Liu X, Datta A, Govindarajan K, Tam WL, Han J, George J, Wong C, Ramnarayanan K, Phua TY, Leong WY, Chan YS, Palanisamy N, Liu ET, Karuturi KM, Lim B, Miller LD (2009) RCP is a human breast cancer-promoting gene with Ras-activating function. J Clin Invest 119:2171\u20132183. https:\/\/doi.org\/10.1172\/JCI37622","journal-title":"J Clin Invest"},{"key":"1396_CR40","doi-asserted-by":"publisher","first-page":"107879","DOI":"10.1016\/j.celrep.2020.107879","volume":"32","author":"S Zhang","year":"2020","unstructured":"Zhang S, Wang C, Ma B, Xu M, Xu S, Liu J, Tian Y, Fu Y, Luo Y (2020) Mutant p53 drives cancer metastasis via RCP-mediated Hsp90alpha secretion. Cell Rep 32:107879. https:\/\/doi.org\/10.1016\/j.celrep.2020.107879","journal-title":"Cell Rep"},{"key":"1396_CR41","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s13402-020-00532-6","volume":"43","author":"J Zhao","year":"2020","unstructured":"Zhao J, Wu J, Qin Y, Zhang W, Huang G, Qin L (2020) LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3\/Slug axis and epithelial-to-mesenchymal transition in gastric cancer. Cell Oncol (dordr) 43:863\u2013876. https:\/\/doi.org\/10.1007\/s13402-020-00532-6","journal-title":"Cell Oncol (dordr)"},{"key":"1396_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mce.2017.01.010","volume":"451","author":"AA Zulkifli","year":"2017","unstructured":"Zulkifli AA, Tan FH, Putoczki TL, Stylli SS, Luwor RB (2017) STAT3 signaling mediates tumour resistance to EGFR targeted therapeutics. Mol Cell Endocrinol 451:15\u201323. https:\/\/doi.org\/10.1016\/j.mce.2017.01.010","journal-title":"Mol Cell Endocrinol"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01396-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-022-01396-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01396-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T04:39:06Z","timestamp":1658810346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-022-01396-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1396"],"URL":"https:\/\/doi.org\/10.1007\/s12272-022-01396-0","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}